Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Norwegian tenecteplase stroke trial (NOR-TEST): randomised controlled trial of tenecteplase vs. alteplase in acute ischaemic stroke.
Logallo N, Kvistad CE, Nacu A, Naess H, Waje-Andreassen U, Asmuss J, Aamodt AH, Lund C, Kurz MW, Rønning OM, Salvesen R, Idicula TT, Thomassen L. Logallo N, et al. Among authors: ronning om. BMC Neurol. 2014 May 15;14:106. doi: 10.1186/1471-2377-14-106. BMC Neurol. 2014. PMID: 24886064 Free PMC article. Clinical Trial.
A pragmatic approach to sonothrombolysis in acute ischaemic stroke: the Norwegian randomised controlled sonothrombolysis in acute stroke study (NOR-SASS).
Nacu A, Kvistad CE, Logallo N, Naess H, Waje-Andreassen U, Aamodt AH, Solhoff R, Lund C, Tobro H, Rønning OM, Salvesen R, Idicula TT, Thomassen L. Nacu A, et al. Among authors: ronning om. BMC Neurol. 2015 Jul 11;15:110. doi: 10.1186/s12883-015-0359-4. BMC Neurol. 2015. PMID: 26162826 Free PMC article. Clinical Trial.
Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial.
Logallo N, Novotny V, Assmus J, Kvistad CE, Alteheld L, Rønning OM, Thommessen B, Amthor KF, Ihle-Hansen H, Kurz M, Tobro H, Kaur K, Stankiewicz M, Carlsson M, Morsund Å, Idicula T, Aamodt AH, Lund C, Næss H, Waje-Andreassen U, Thomassen L. Logallo N, et al. Among authors: ronning om. Lancet Neurol. 2017 Oct;16(10):781-788. doi: 10.1016/S1474-4422(17)30253-3. Epub 2017 Aug 2. Lancet Neurol. 2017. PMID: 28780236 Clinical Trial.
Stroke incidence in the young: evidence from a Norwegian register study.
Barra M, Labberton AS, Faiz KW, Lindstrøm JC, Rønning OM, Viana J, Dahl FA, Rand K. Barra M, et al. Among authors: ronning om. J Neurol. 2019 Jan;266(1):68-84. doi: 10.1007/s00415-018-9102-6. Epub 2018 Oct 30. J Neurol. 2019. PMID: 30377817 Free PMC article.
[Indications for thrombectomy].
Aamodt AH, Kurz M, Jacobsen EA, Totland JA, Rønning OM, Thomassen L, Lund CG, Næss H. Aamodt AH, et al. Among authors: ronning om. Tidsskr Nor Laegeforen. 2018 Oct 30;138(17). doi: 10.4045/tidsskr.18.0771. Print 2018 Oct 30. Tidsskr Nor Laegeforen. 2018. PMID: 30378416 Free article. Norwegian. No abstract available.
Safety and Outcomes of Tenecteplase in Moderate and Severe Ischemic Stroke.
Kvistad CE, Novotny V, Kurz MW, Rønning OM, Thommessen B, Carlsson M, Waje-Andreassen U, Næss H, Thomassen L, Logallo N. Kvistad CE, et al. Among authors: ronning om. Stroke. 2019 May;50(5):1279-1281. doi: 10.1161/STROKEAHA.119.025041. Stroke. 2019. PMID: 31009339 Clinical Trial.
Sex differences in the Norwegian Tenecteplase Trial (NOR-TEST).
Ihle-Hansen H, Sandset EC, Ihle-Hansen H, Hagberg G, Thommessen B, Rønning OM, Kvistad CE, Novotny V, Naess H, Waje-Andreassen U, Thomassen L, Logallo N. Ihle-Hansen H, et al. Among authors: ronning om. Eur J Neurol. 2022 Feb;29(2):609-614. doi: 10.1111/ene.15126. Epub 2021 Oct 4. Eur J Neurol. 2022. PMID: 34564893 Clinical Trial.
104 results